PPD Earns Gold Award for Excellence in Employee Learning and Development
21 Settembre 2021 - 3:00PM
Business Wire
PPD, Inc. (Nasdaq: PPD) has been recognized with two global
excellence awards for its effective learning programs, honoring the
company’s high-performing employee development initiatives
supporting delivery of global operational excellence and innovative
solutions to customers.
For the second consecutive year, PPD received two Brandon Hall
Group Human Capital Management (HCM) “Excellence in Learning”
Awards. This year’s honors include a gold award for “Best Advance
of a Learning Technology Implementation” and a bronze award in the
category of “Best Results of a Learning Program.”
PPD was honored with a gold award for its successful execution
in leveraging technology to expand learning capabilities through
mobile training, as well as the implementation of a learning
experience platform, offering professional development skills
training across the company.
“We implemented an extensive redesign of our training delivery,
which has increased accessibility and given our employees greater
flexibility in choosing how and when they learn, while reinforcing
the organization’s mission and strategy,” said Jay Dixon, senior
vice president of quality and enterprise learning at PPD. “This
gold award reflects our success in enhancing employee training to
help guide and drive business results for our customers.”
PPD’s learning and development programs are structured to
improve business performance to help fulfill a company objective of
fostering industry-leading talent and culture. The curriculum
includes leadership and high-potential development, key talent
programs, technical skills, and job-specific and soft-skills
training, all of which support employee development and enable PPD
to provide exceptional customer service. PPD’s learning culture is
focused on a talent-development mindset, which has been effective
in assisting employees to grow within the organization and
attracting high-caliber applicants. As recognized by this award,
PPD’s improvements in learning technology have dramatically
enhanced the employee learning experience.
The bronze award in the category of “Best Results of a Learning
Program” was awarded to PPD and Explorance, a learning analytics
vendor, for their collaborative work on Biotech University (BTU).
PPD’s internal enterprise learning team developed BTU, a
competency-based program, for employees who serve biotech
customers, with the goal of enhancing critical thinking skills,
customer service and solutions delivery.
“Explorance is delighted to support PPD in their development of
Biotech University,” said Samer Saab, chief executive officer of
Explorance. “PPD leveraged Metrics That Matter (MTM), Explorance’s
Learning and Development (L&D) effectiveness solution, to make
clear how L&D programs contribute to business goals. MTM’s
ability to critically assess L&D efforts, such as those at PPD
and BTU, makes it an important pillar in an overall employee
experience management strategy, transforming insight into
action.”
The Brandon Hall Group HCM Excellence Awards feature two annual
programs that recognize organizations that have successfully
deployed programs, strategies, modalities, processes, systems and
tools that have achieved measurable results in learning and
development.
This year’s awards build on the momentum established in 2020
when PPD was recognized with the Brandon Hall Gold Award in two
categories – “Best Use of Blended Learning” for its clinical
foundation program, which prepares clinical development employees
for success in trial monitoring, and “Best Advance in Learning
Measurement” for the company’s ability to measure learning
effectiveness.
About PPD
PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and
lifecycle management services. Our customers and partners include
pharmaceutical, biotechnology, medical device, academic and
government organizations. With more than 28,000 professionals
worldwide, PPD has conducted clinical trials in more than 100
countries to help customers deliver life-changing therapies to
improve health. We apply innovative technologies, therapeutic
expertise and a firm commitment to quality to bend the cost and
time curve of drug development and optimize value. For more
information, visit www.ppd.com.
About Explorance
Explorance is an innovative experience management solution
provider that empowers organizations in making personalized and
impactful decisions with feedback data. Explorance reimagines how
experience management can impact the lifelong learner's journey, by
breaking down segmented data silos so you can connect the dots and
make the best possible decisions. To learn more, please visit
www.explorance.com and follow us on LinkedIn and Twitter
@explorance.
This news release contains forward-looking statements. These
statements often include words such as “expect,” “believe,”
“project,” “forecast,” “estimate,” “target” and other similar
expressions. Although we believe these forward-looking statements
are based on reasonable assumptions at the time they are made, you
should be aware that many factors could affect our actual financial
results, and therefore actual results might differ materially from
those expressed in the forward-looking statements. Factors that
might materially affect such forward-looking statements include,
but are not limited to, the fragmented and highly competitive
nature of the drug development services industry; changes in trends
in the biopharmaceutical industry; our ability to keep pace with
rapid technological changes that could make our services less
competitive or obsolete; political, economic and/or regulatory
influences and changes; the risks related to the proposed merger of
PPD by Thermo Fisher Scientific Inc.; and other factors disclosed
under the “Risk Factors” section in our periodic reports filed with
the Securities and Exchange Commission (SEC), including our latest
Annual Report on Form 10-K and Quarterly Report on form 10-Q, which
are available on our website at https://investors.ppd.com or the
SEC’s website at www.sec.gov. We assume no obligation and disclaim
any duty to revise or update any forward-looking statements, or
make any new forward-looking statement, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210921005674/en/
PPD Contacts Media: Nadine Maeser 1 910 558 4779
media@ppd.com Investors: Tracy Krumme +1 910 558 4186
investors@ppd.com
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Ott 2023 a Ott 2024